These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36358216)

  • 1. Chimeric Peptides Derived from Bovine Lactoferricin and Buforin II: Antifungal Activity against Reference Strains and Clinical Isolates of
    Aguirre-Guataqui K; Márquez-Torres M; Pineda-Castañeda HM; Vargas-Casanova Y; Ceballos-Garzon A; Rivera-Monroy ZJ; García-Castañeda JE; Parra-Giraldo CM
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Antifungal Activity of Chimeric Peptides Derived from Bovine Lactoferricin and Buforin II against
    Carvajal SK; Vargas-Casanova Y; Pineda-Castañeda HM; García-Castañeda JE; Rivera-Monroy ZJ; Parra-Giraldo CM
    Antibiotics (Basel); 2022 Dec; 11(12):. PubMed ID: 36551475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing Chimeric Peptides: A Powerful Tool for Enhancing Antibacterial Activity.
    Pineda-Castañeda HM; Huertas-Ortiz KA; Leal-Castro AL; Vargas-Casanova Y; Parra-Giraldo CM; García-Castañeda JE; Rivera-Monroy ZJ
    Chem Biodivers; 2021 Feb; 18(2):e2000885. PubMed ID: 33369144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents Against Clinically Relevant Gram-Positive and Gram-Negative Pathogens.
    Vega SC; Martínez DA; Chalá MDS; Vargas HA; Rosas JE
    Front Microbiol; 2018; 9():329. PubMed ID: 29551999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining the Peptide RWQWRWQWR and an Ethanolic Extract of
    Vargas-Casanova Y; Bravo-Chaucanés CP; Martínez AXH; Costa GM; Contreras-Herrera JL; Medina RF; Rivera-Monroy ZJ; García-Castañeda JE; Parra-Giraldo CM
    J Fungi (Basel); 2023 Aug; 9(8):. PubMed ID: 37623588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic bactericide and antibiotic effects of dimeric, tetrameric, or palindromic peptides containing the RWQWR motif against Gram-positive and Gram-negative strains.
    Vargas-Casanova Y; Rodríguez-Mayor AV; Cardenas KJ; Leal-Castro AL; Muñoz-Molina LC; Fierro-Medina R; Rivera-Monroy ZJ; García-Castañeda JE
    RSC Adv; 2019 Mar; 9(13):7239-7245. PubMed ID: 35519960
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Antifungal Activity of Three Synthetic Peptides against
    Torres R; Barreto-Santamaría A; Arévalo-Pinzón G; Firacative C; Gómez BL; Escandón P; Patarroyo MA; Muñoz JE
    Antibiotics (Basel); 2023 Jul; 12(8):. PubMed ID: 37627654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.
    Vega Chaparro SC; Valencia Salguero JT; Martínez Baquero DA; Rosas Pérez JE
    Biomed Res Int; 2018; 2018():5252891. PubMed ID: 29984236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species.
    Zhang J; Liu W; Tan J; Sun Y; Wan Z; Li R
    Mycopathologia; 2013 Apr; 175(3-4):273-9. PubMed ID: 23341047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
    Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
    J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indifferent effect of nonsteroidal anti-inflammatory drugs (NSAIDs) combined with fluconazole against multidrug-resistant
    Ahangarkani F; Khodavaisy S; Mahmoudi S; Shokohi T; Rezai MS; Fakhim H; Dannaoui E; Faraji S; Chowdhary A; Meis JF; Badali H
    Curr Med Mycol; 2019 Sep; 5(3):26-30. PubMed ID: 31850393
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Quindós G; Miranda-Cadena K; San-Millán R; Borroto-Esoda K; Cantón E; Linares-Sicilia MJ; Hamprecht A; Montesinos I; Tortorano AM; Prigitano A; Vidal-García M; Marcos-Arias C; Guridi A; Sanchez-Reus F; Machuca-Bárcena J; Rodríguez-Iglesias MA; Martín-Mazuelos E; Castro-Méndez C; López-Soria L; Ruiz-Gaitán A; Fernandez-Rivero M; Lorenzo D; Capilla J; Rezusta A; Pemán J; Guarro J; Pereira J; Pais C; Romeo O; Ezpeleta G; Jauregizar N; Angulo D; Eraso E
    Front Cell Infect Microbiol; 2022; 12():906563. PubMed ID: 35651755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
    Zhang M; Yan H; Lu M; Wang D; Sun S
    Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of novel synthetic dodecapeptides against Candida albicans.
    Maurya IK; Thota CK; Sharma J; Tupe SG; Chaudhary P; Singh MK; Thakur IS; Deshpande M; Prasad R; Chauhan VS
    Biochim Biophys Acta; 2013 Nov; 1830(11):5193-203. PubMed ID: 23876294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal effects and potential mechanisms of lonidamine in combination with fluconazole against
    Chen X; Shi Y; Li Y; Su S; Wang P; Sun S
    Expert Rev Anti Infect Ther; 2021 Jan; 19(1):109-115. PubMed ID: 32924656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.